Oncolytics Biotech buy El_Zocko
Summary
This prediction ended on 16.06.15 with a price of €4.87. The prediction for Oncolytics Biotech disappointed with a performance of -27.75%. El_Zocko has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Oncolytics Biotech | - | - | - | - |
iShares Core DAX® | -0.552% | 3.405% | 17.621% | 18.214% |
iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% | 54.410% |
iShares Nikkei 225® | -0.877% | -1.396% | 9.284% | 4.292% |
iShares S&P 500 | -0.415% | 3.338% | 25.914% | 47.401% |
Comments by El_Zocko for this prediction
In the thread Oncolytics Biotech diskutieren
Runde 2 im Zock - ONCOLYTICS BIOTECH
Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. The Company is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. Oncolytics’ clinical program includes a number of human trials at a variety of stages including a Phase III trial in head and neck cancers. The Company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.
Quelle: http://www.oncolyticsbiotech.com/